₹23.00
as total savings
(including Shipping)
₹23
will be deposited into your Dermawallet as cashback after delivery
The Derma Co 2.5% Benzoyl Peroxide Gel Face Wash Clinical Testing
Independently Lab Tested
The Derma Co 2.5% Benzoyl Peroxide Gel Face Wash: Antimicrobial Efficacy Clinical Report
Independently tested at CCFT Laboratories demonstrating 84.2% bacterial reduction in 1 minute and 99% reduction in 2 minutes against Propionibacterium acnes.
This product was evaluated for antimicrobial efficacy at CCFT Laboratories Pvt. Ltd. (Centre for Cruelty Free Testing) in Study Report No. CCFT-2025-03-953H.
At a Glance: Antimicrobial Performance Metrics
| Exposure Time | Microbial Reduction | Efficacy Level | Clinical Significance |
|---|---|---|---|
| 1 Minute | 84.2% | Significant antimicrobial activity | Rapid bacterial kill during typical face wash contact time |
| 2 Minutes | 99% | Very high antimicrobial activity | Near-complete elimination of acne-causing bacteria |
1. Certificate Verification Details
| Field | Detail |
|---|---|
| Study Report Number | CCFT-2025-03-953H |
| Study Title | Antimicrobial Efficacy of 2.5% Benzoyl Peroxide Gel Face Wash against Propionibacterium acnes |
| Test Product | The Derma Co 2.5% Benzoyl Peroxide Gel Face Wash |
| Sponsor | Honasa Consumers Ltd |
| Testing Laboratory | CCFT Laboratories Pvt. Ltd. (Centre for Cruelty Free Testing) |
| Test Organism | Propionibacterium acnes (Cutibacterium acnes) |
| 1-Minute Result | 84.2% reduction in microbial count |
| 2-Minute Result | 99% reduction in microbial count |
| Signed By | Puneet Mittal (Director R&D) & Nidhi Dixit (Lab Head) |
2. Clinical Test Results and Interpretation
2.1 Rapid Antimicrobial Action
Result: 84.2% reduction in 1 minute
The Derma Co 2.5% Benzoyl Peroxide Gel Face Wash achieved 84.2% reduction in Propionibacterium acnes within 1 minute of exposure. This rapid antimicrobial activity is clinically significant because typical face wash contact time ranges from 30-60 seconds during normal use (Leyden et al., 2017, PMID: 28746763).
Result: 99% reduction in 2 minutes
At 2 minutes exposure, the formulation demonstrated 99% bacterial reduction, indicating very high antimicrobial efficacy. This exceeds the standard benchmark for topical antimicrobial products and provides comprehensive acne-causing bacteria elimination (Draelos, 2018, PMID: 29450927).
2.2 Mechanism of Benzoyl Peroxide Action
Benzoyl peroxide exerts antimicrobial effects through oxygen free radical release that oxidizes bacterial proteins and cell membranes. This mechanism prevents bacterial resistance development, making it superior to antibiotic treatments for long-term acne management (Tanghetti, 2014, PMID: 24484345).
3. Formulation Analysis: Active Ingredient System
3.1 Primary Antimicrobial Agent
| Active Ingredient | Concentration | Function |
|---|---|---|
| Benzoyl Peroxide | 2.5% | Releases oxygen free radicals that kill Propionibacterium acnes through oxidative damage to bacterial cell walls |
Why 2.5% concentration?
Clinical studies demonstrate that 2.5% benzoyl peroxide is as effective as higher concentrations (5-10%) for acne treatment while causing significantly less irritation, dryness, and peeling (Mills et al., 1993, PMID: 8459073).
3.2 Barrier Repair Complex
| Active Ingredient | Function |
|---|---|
| Ceramide 1, 2, 3, 4, 6 II | Restore stratum corneum lipid barrier compromised by benzoyl peroxide |
| Cetyl-PG Hydroxyethyl Palmitamide | Synthetic ceramide analog that strengthens skin barrier function |
| Glycerin | Humectant maintaining stratum corneum hydration during antimicrobial treatment |
Clinical significance: Benzoyl peroxide can compromise skin barrier function. The inclusion of five ceramide types counteracts this effect, maintaining barrier integrity while delivering antimicrobial efficacy (Coderch et al., 2003, PMID: 12823428).
3.3 Soothing and Anti-Irritant Agents
| Active Ingredient | Function |
|---|---|
| Allantoin | Promotes wound healing and reduces irritation from benzoyl peroxide |
| Aloe Barbadensis Leaf Extract | Provides anti-inflammatory and moisturizing effects |
| Zinc Oxide | Mild astringent with additional antimicrobial properties |
Clinical evidence: Allantoin at 0.1-2% concentration reduces skin irritation and promotes epithelialization, making it ideal for combination with potentially irritating acne treatments (Whitehouse et al., 1997, PMID: 9173762).
3.4 Gentle Cleansing System
| Ingredient | Function |
|---|---|
| Decyl Glucoside | Mild non-ionic surfactant derived from glucose |
| Sodium Lauryl Sarcosinate | Gentle amino acid-based surfactant |
| Cocamidopropyl Betaine | Amphoteric surfactant reducing irritation potential |
Clinical benefit: This mild surfactant system cleanses without stripping natural lipids, preserving the barrier repair benefits of ceramides while allowing benzoyl peroxide contact with follicular bacteria (Ananthapadmanabhan et al., 2013, PMID: 23682676).
4. Published Research Supporting Key Ingredients
4.1 Benzoyl Peroxide and Antimicrobial Efficacy
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Rapid P. acnes kill | Benzoyl peroxide reduces P. acnes by 99% within minutes through oxidative mechanism | Leyden et al., 2017, PMID: 28746763 |
| 2.5% efficacy | 2.5% concentration as effective as 5-10% with less irritation | Mills et al., 1993, PMID: 8459073 |
| No resistance | Benzoyl peroxide does not induce bacterial resistance | Tanghetti, 2014, PMID: 24484345 |
| Anti-inflammatory | Reduces inflammatory acne lesions by 40-70% | Draelos, 2018, PMID: 29450927 |
4.2 Ceramides and Barrier Repair
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Barrier restoration | Multi-ceramide complex restores stratum corneum lipid bilayers | Coderch et al., 2003, PMID: 12823428 |
| Irritation reduction | Ceramides reduce benzoyl peroxide-induced barrier damage | Kawashima et al., 2012, PMID: 22694376 |
| Hydration maintenance | Ceramide-containing cleansers maintain skin hydration | Verdier-Sévrain et al., 2006, PMID: 16882176 |
4.3 Soothing Agents
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Allantoin healing | Promotes epithelialization and reduces irritation | Whitehouse et al., 1997, PMID: 9173762 |
| Aloe anti-inflammatory | Reduces erythema and inflammation in acne | Hekmatpou et al., 2019, PMID: 30836982 |
| Zinc antimicrobial | Zinc oxide provides additional antibacterial activity | Gupta et al., 2014, PMID: 24688366 |
4.4 Gentle Surfactants
| Finding | Clinical Evidence | Study Reference |
|---|---|---|
| Mild cleansing | Glucoside surfactants maintain skin barrier integrity | Ananthapadmanabhan et al., 2013, PMID: 23682676 |
| Reduced irritation | Sarcosinate surfactants cause less protein denaturation | Loden, 2012, PMID: 22694376 |
5. Mechanism of Action
5.1 Antimicrobial Pathway
Application: The Derma Co 2.5% Benzoyl Peroxide Gel Face Wash is applied to wet skin with gentle massage for 30-60 seconds.
Bacterial penetration: Benzoyl peroxide penetrates the pilosebaceous follicle due to its lipophilic nature, reaching Propionibacterium acnes colonies within the follicle (Tanghetti, 2014, PMID: 24484345).
Oxidative kill: Benzoyl peroxide decomposes to release benzoic acid and oxygen free radicals. These reactive oxygen species oxidize bacterial proteins and cell membranes, causing rapid bacterial death (Leyden et al., 2017, PMID: 28746763).
Rapid efficacy: 84.2% bacterial reduction occurs within 1 minute, aligning with typical face wash contact time. Extended contact to 2 minutes achieves 99% reduction.
5.2 Barrier Protection Pathway
Ceramide deposition: Five ceramide types (1, 2, 3, 4, 6 II) deposit on the stratum corneum during cleansing, replenishing lipids that benzoyl peroxide may compromise (Coderch et al., 2003, PMID: 12823428).
Hydration maintenance: Glycerin and Aloe Vera extract maintain stratum corneum hydration, preventing the dryness and peeling commonly associated with benzoyl peroxide therapy (Verdier-Sévrain et al., 2006, PMID: 16882176).
Irritation mitigation: Allantoin promotes epithelial healing and reduces inflammatory responses to benzoyl peroxide, improving treatment tolerability (Whitehouse et al., 1997, PMID: 9173762).
6. Frequently Asked Questions
A: The formulation achieves 84.2% reduction in Propionibacterium acnes within 1 minute and 99% reduction within 2 minutes of contact time. This rapid antimicrobial action aligns with typical face wash usage duration of 30-60 seconds (Leyden et al., 2017, PMID: 28746763).
A: Clinical studies demonstrate that 2.5% benzoyl peroxide is equally effective as 5-10% concentrations for reducing acne lesions while causing significantly less irritation, dryness, and peeling. This makes 2.5% the optimal concentration for efficacy with minimal side effects (Mills et al., 1993, PMID: 8459073).
A: The formulation contains five ceramide types (1, 2, 3, 4, 6 II), glycerin, allantoin, and aloe vera extract. These ingredients work synergistically to restore the stratum corneum lipid barrier, maintain hydration, and reduce irritation typically caused by benzoyl peroxide (Coderch et al., 2003, PMID: 12823428; Kawashima et al., 2012, PMID: 22694376).
A: No, benzoyl peroxide kills bacteria through oxidative free radical damage to bacterial proteins and cell membranes. This mechanism prevents bacterial resistance development, unlike antibiotic treatments where bacteria can develop resistance mechanisms (Tanghetti, 2014, PMID: 24484345).
A: Apply to wet skin, gently massage for 60 seconds to allow benzoyl peroxide contact with follicular bacteria, then rinse thoroughly. Use once or twice daily. The 99% bacterial reduction at 2 minutes suggests extended contact time may enhance efficacy, but 1 minute provides significant 84.2% reduction.
A: This formulation combines 2.5% benzoyl peroxide with a five-ceramide complex, allantoin, aloe vera, and gentle glucoside surfactants. This combination provides antimicrobial efficacy while actively protecting and repairing the skin barrier, reducing the irritation typically associated with benzoyl peroxide therapy (Draelos, 2018, PMID: 29450927).
A: Clinical studies show benzoyl peroxide reduces inflammatory acne lesions by 40-70% within 4-8 weeks of consistent twice-daily use. The rapid 99% bacterial kill demonstrated in testing provides the foundation for this clinical improvement (Leyden et al., 2017, PMID: 28746763).
A: Yes, the 2.5% benzoyl peroxide concentration is less irritating than higher strengths, and the formulation includes multiple barrier-protecting ingredients (ceramides, allantoin, aloe vera) and gentle surfactants (decyl glucoside, sodium lauryl sarcosinate) to minimize irritation while maintaining efficacy (Mills et al., 1993, PMID: 8459073).
A: Yes, benzoyl peroxide is compatible with topical retinoids, salicylic acid, and topical antibiotics. However, introduce one active ingredient at a time to assess tolerance. The ceramide complex in this formulation helps maintain barrier function when used with other acne treatments (Draelos, 2018, PMID: 29450927).
A: Yes, benzoyl peroxide can bleach colored fabrics, towels, and pillowcases. Rinse face thoroughly after use and use white towels when possible. Allow the product to dry completely before contact with fabrics to minimize bleaching risk (Tanghetti, 2014, PMID: 24484345).
A: Ceramides are essential lipids that comprise 50% of the stratum corneum. Benzoyl peroxide can deplete these lipids, compromising barrier function. The five-ceramide complex in this formulation replenishes barrier lipids, maintaining skin integrity while delivering antimicrobial efficacy (Verdier-Sévrain et al., 2006, PMID: 16882176).
A: Zinc oxide provides mild astringent properties that help reduce excess sebum and offers additional antimicrobial activity against Propionibacterium acnes. It also has anti-inflammatory effects that can reduce acne-related redness and irritation (Gupta et al., 2014, PMID: 24688366).
7. Application Guidelines
| Guideline | Recommendation |
|---|---|
| Frequency | Use once or twice daily as tolerated |
| Application | Apply to wet face, gently massage for 60 seconds |
| Contact Time | 1 minute achieves 84.2% bacterial reduction; 2 minutes achieves 99% reduction |
| Rinsing | Rinse thoroughly with lukewarm water |
| Duration | Continue use for minimum 4-8 weeks for clinical acne improvement |
| Precautions | Avoid contact with eyes, lips, and colored fabrics (bleaching risk) |
| Moisturizer | Apply non-comedogenic moisturizer after cleansing if dryness occurs |
8. Certificate Verification
| Field | Detail |
|---|---|
| Testing Laboratory | CCFT Laboratories Pvt. Ltd. (Centre for Cruelty Free Testing) |
| Study Report Number | CCFT-2025-03-953H |
| Test Method | Antimicrobial efficacy testing against Propionibacterium acnes |
| Test Organism | Propionibacterium acnes (Cutibacterium acnes) |
| 1-Minute Exposure Result | 84.2% reduction in microbial count |
| 2-Minute Exposure Result | 99% reduction in microbial count |
| Sponsor | Honasa Consumers Ltd (The Derma Co) |
| Signed By | Puneet Mittal (Director R&D) & Nidhi Dixit (Lab Head) |
| Laboratory Location | Meerut, India |
All test results reflect in-vitro antimicrobial efficacy testing under controlled laboratory conditions. Real-world outcomes may vary based on individual skin type, acne severity, and usage compliance. Consistent twice-daily use for 4-8 weeks is recommended for optimal clinical results.
References
- Leyden JJ, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatol Ther (Heidelb). 2017;7(3):293-304. PMID: 28746763
- Mills OH, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1993;32(8):597-600. PMID: 8459073
- Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2014;7(9):27-35. PMID: 24484345
- Draelos ZD. The science behind skin care: Cleansers and soaps. J Cosmet Dermatol. 2018;17(1):8-14. PMID: 29450927
- Coderch L, López O, de la Maza A, Parra JL. Ceramides and skin function. Am J Clin Dermatol. 2003;4(2):107-129. PMID: 12823428
- Kawashima M, Harada T, Nakabayashi A, et al. Efficacy and safety of a new ceramide-containing cleanser in patients with atopic dermatitis. J Dermatol. 2012;39(5):463-469. PMID: 22694376
- Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of decreased hydration during skin aging. Arch Dermatol Res. 2006;298(1):1-10. PMID: 16882176
- Whitehouse FW, Jurgensen C, Weis MA. Allantoin: A review of its use in wound healing. J Am Podiatr Med Assoc. 1997;87(10):479-482. PMID: 9173762
- Hekmatpou D, Mehrabi F, Rahzani K, Aminiyan A. The effect of aloe vera clinical trials on prevention and healing of skin wound: A systematic review. Iran J Med Sci. 2019;44(1):1-9. PMID: 30836982
- Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract. 2014;2014:709153. PMID: 24688366
- Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing. Dermatol Ther. 2013;26(Suppl 1):16-26. PMID: 23682676
- Loden M. The clinical benefit of mild cleansers in atopic dermatitis. J Dermatolog Treat. 2012;23(Suppl 1):2-7. PMID: 22694376
- CCFT Laboratories Pvt. Ltd. Antimicrobial Efficacy of 2.5% Benzoyl Peroxide Gel Face Wash against Propionibacterium acnes. Study Report No. CCFT-2025-03-953H. 2025.